by ELISA is a commonly used biomedical technique which employs antibodies and color change to identify a substance such as a protein. It has applications ranging from clinical diagnostics to bioengineering research to food safety testing. The recognition antibodies or antigens are attached to a solid surface and any unbound material is washed away. The analyte can then be detected using a reporter enzyme system where the enzyme catalyzes a reaction which produces a detectable signal like color change which is proportional to the amount of analyte present. Global demand for ELISA is driven by its wide usage for detecting antibodies, hormones and other biomarkers in clinical applications.
The enzyme linked immunosorbent assay (ELISA) market is estimated to be valued at US$ 2441 Mn in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period from 2024 to 2030.
Key Takeaways
The key players operating in the enzyme linked immunosorbent assay (ELISA) market are DSV, a.p. moller – maersk, United Parcel Service of America, Inc., XPO Logistics Inc., DHL International GmbH, Kuehne+Nagel Inc., Geodis, FedEx Corporation, C.H. Robinson Worldwide, Inc..
The key opportunities in the ELISA market include development of multiplex ELISA technology which allows simultaneous detection of multiple analytes in a single well. This has increased throughput and reduced costs.
Advancement in automation and robotics used for liquid handling and plate reading has improved reproducibility and reduced manual labor required for ELISA experiments. Growing applications of ELISA in areas of food safety, environmental monitoring and veterinary testing are also projected to fuel market growth over the forecast period.
Market Drivers
Growth in the biotechnology and pharmaceutical industries has increased the R&D investments in areas such as protein therapeutics, monoclonal antibodies and recombinant proteins driving demand for ELISA as an indispensable detection technique. Rising prevalence of chronic and infectious diseases have augmented clinical diagnostics revenues which acts as a major market driver. Growing geriatric population and awareness of disease screening are other factors contributing to ELISA market growth.
Current challenges in Enzyme Linked Immunosorbent Assay (ELISA) Market
The Elisa Market is facing challenges like high cost associated with ELISA kits and reagents. There is lack of availability of low cost immunoassay alternatives for middle and low-income countries. Interpretation of ELISA results and improper storage also poses challenges. Further, issues like short shelf life of some ELISA kits and lack of validation of many kits available in the market affects the market growth.
SWOT Analysis
Strength: ELISA techniques are highly sensitive and suitable for detection of antigens and antibodies. It has wide applications in research, diagnostics and food testing.
Weakness: ELISA is a multi-step process and handling of numerous reagents increases chance of errors. Require well-trained lab personnel for proper execution of assay.
Opportunity: Growing fields like proteomics, metabolomics presents new applications. Increasing focus on development of point of care kits, microfluidic ELISA and multiplexing creates opportunities.
Threats: Alternate techniques like western blotting, rapid tests poses competition. Regulatory issues and standards affects market acceptability.
In terms of value, North America accounts for the largest share in ELISA market owing to growing research activities and diagnostic applications. Presence of global key players and availability of advanced healthcare infrastructure supports market growth. Europe is the second largest market led by improving research funding and rising adoption of personalized medicine approach. Asia Pacific region is expected to witness fastest growth during the forecast period due to increasing governmental support for healthcare sector, large population and rise in disposable income. Further, expansion of key players in emerging economies augurs well for market growth.
The ELISA market in Middle East and Africa is expected to grow at a steady pace owing to improving healthcare infrastructure and economic development in some countries. Latin America also presents opportunities for players due to rising healthcare expenditure and government initiatives to expand diagnosticsaccessibility in the region. However, lack of awareness and socio-economic challenges may hamper market penetration in some parts.
